SPC507
Repotrectinib and/or pharmaceutically acceptable salts and esters thereof
Status:
UmsóknApplication date:
3.4.2025Application published:
1.5.2025
Medicine name:
AugtyroMedicine for children:
No
Timeline
Today
3.4.2025Application
1.5.2025Publication
Marketing license
Foreign authorization number:
EU/1/24/1883/001-004Date:
13.1.2025
Owner
Name:
Turning Point Therapeutics, Inc.Address:
Route 206 and Province Line Road, Princeton, NJ 08543 US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP3572416